{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:32:46Z","timestamp":1774611166856,"version":"3.50.1"},"reference-count":107,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Croatian Society for Kidney, Croatian Medical Association"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Regenerative medicine shows significant potential in treating kidney diseases through the application of various types of stem and progenitor cells, including mesenchymal stem cells (MSCs), renal stem\/progenitor cells, embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs). Stem cells possess the unique ability to repair injured organs and improve impaired functions, making them a key element in the research of therapies for kidney tissue repair and organ regeneration. In kidney transplantation, reperfusion injury can cause tissue destruction, leading to an initially low glomerular filtration rate and long-term impact on function by creating irreversible interstitial fibrosis. MSCs have proven useful in repairing early tissue injury in animal models of kidney, lung, heart, and intestine transplantation. The use of stem cell therapies in solid organ transplantation raises the question of whether autologous or allogeneic cells should be preferred. Adipose-derived stem cells (ASCs), characterized by the lack of HLA Class II molecules and low expression of HLA Class I and co-stimulatory signals, are considered immune-privileged. However, the actual risk of graft rejection associated with allogeneic ASCs remains unclear. It has been demonstrated that donor-derived ASCs can promote the development of Treg cells in vitro, and some degree of tolerance induction has been observed in vivo. Nevertheless, a study comparing the efficacy of autologous and allogeneic ASCs in a rat model with a total MHC mismatch for kidney transplantation showed that donor-derived administration of ASCs did not improve the grafts\u2019 survival and was associated with increased mortality through an immunologically mediated mechanism. Given the lack of data, autologous ASCs appear to be a safer option in this research context. The aim of this review was to examine the differences between autologous and allogeneic ASCs in the context of their application in kidney transplantation therapies, considering potential immune reactions and therapeutic efficacy. Some have argued that ASCs harvested from end-stage renal disease (ESRD) patients may have lower regenerative potential due to the toxic effects of uremia, potentially limiting their use in transplantation settings. However, evidence suggests that the beneficial properties of ASCs are not affected by uremia or dialysis. Indeed, some investigators have demonstrated that ASCs harvested from chronic kidney disease (CKD) patients exhibit normal characteristics and function, maintaining consistent proliferative capacity and genetic stability over time, even after prolonged exposure to uremic serum Furthermore, no differences were observed in the response of ASCs to immune activation or their inhibitory effect on the proliferation of alloantigen-activated peripheral blood mononuclear cells between patients with normal or impaired renal function. This review presents the current achievements in stem cell research aimed at treating kidney diseases, highlighting significant progress and ongoing efforts in the development of stem cell-based therapies. Despite the encouraging results, further research is needed to overcome the current limitations and fully realize the potential of these innovative treatments. Advances in this field are crucial for developing effective therapies that can address the complex challenges associated with kidney damage and failure.<\/jats:p>","DOI":"10.3390\/jcm13195763","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T06:10:27Z","timestamp":1727417427000},"page":"5763","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of Autologous and Allogeneic Adipose-Derived Stem Cells in Kidney Transplantation: Immunological Considerations and Therapeutic Efficacy"],"prefix":"10.3390","volume":"13","author":[{"given":"Ljiljana","family":"Fodor Duric","sequence":"first","affiliation":[{"name":"Medicol Polyclinic, School of Medicine, Croatian Catholic Unoversity, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolina","family":"Basic Jukic","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Kidney Transplantation, Clinical Hospital Center Zagreb, Faculty of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6536-4786","authenticated-orcid":false,"given":"Bozidar","family":"Vujicic","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Kidney Transplantation, Clinical Hospital Center Rijeka, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Bochon, B., Kozubska, M., Suryga\u0142a, G., Witkowska, A., Ku\u017aniewicz, R., Grzeszczak, W., and Wystrychowski, G. (2019). Mesenchymal Stem Cells\u2014Potential Applications in Kidney Diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102462"},{"key":"ref_2","first-page":"245","article-title":"Stem cells in kidney diseases","volume":"7","author":"Maria","year":"2012","journal-title":"J. Stem Cells"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Bonaventura, G., Chamayou, S., Liprino, A., Guglielmino, A., Fichera, M., Caruso, M., and Barcellona, M.L. (2015). Different Tissue-Derived Stem Cells: A Comparison of Neural Differentiation Capability. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140790"},{"key":"ref_4","first-page":"185","article-title":"Totipotency, pluripotency and nuclear reprogramming","volume":"114","author":"Mitalipov","year":"2009","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/JCN.0b013e318197a6a5","article-title":"Introduction to stem cell therapy","volume":"24","author":"Biehl","year":"2009","journal-title":"J. Cardiovasc. Nurs."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3904\/kjim.2013.28.4.387","article-title":"Clinical applications of mesenchymal stem cells","volume":"28","author":"Kim","year":"2013","journal-title":"Korean J. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3109\/21691401.2015.1129620","article-title":"Implications of mesenchymal stem cells in regenerative medicine","volume":"44","author":"Kariminekoo","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/19768354.2015.1087430","article-title":"Differentiation potential of mesenchymal stem cells isolated from human dental tissues into non-mesodermal lineage","volume":"19","author":"Jeon","year":"2015","journal-title":"Anim. Cells Syst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbrc.2004.12.158","article-title":"Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo","volume":"328","author":"Seo","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1038\/emm.2013.94","article-title":"Mesenchymal stem cells: Environmentally responsive therapeutics for regenerative medicine","volume":"45","author":"Murphy","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1083\/jcb.200810038","article-title":"Nanotubes, exosomes, and nucleic acid-binding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: Implications in health and disease","volume":"183","author":"Belting","year":"2008","journal-title":"J. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13287-018-1069-9","article-title":"Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs","volume":"9","author":"Qiu","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/eji.201041324","article-title":"Human mesenchymal stem cells respond to native but not oxidized damage associated molecular pattern molecules from necrotic (tumor) material","volume":"41","author":"Lotfi","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/cdd.2017.51","article-title":"Mesenchymal stem cells sense mitochondria released from damaged cells as danger signals to activate their rescue properties","volume":"24","author":"Augeul","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1073\/pnas.0510511103","article-title":"Mitochondrial transfer between cells can rescue aerobic respiration","volume":"103","author":"Spees","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/cdd.2014.211","article-title":"Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells","volume":"22","author":"Wang","year":"2015","journal-title":"Cell Death Differ."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e2467","DOI":"10.1038\/cddis.2016.358","article-title":"Mitochondrial transfer of mesenchymal stem cells effectively protects corneal epithelial cells from mitochondrial damage","volume":"7","author":"Jiang","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nm.2736","article-title":"Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury","volume":"18","author":"Islam","year":"2012","journal-title":"Nat. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mvr.2014.01.008","article-title":"Mesenchymal stem cells rescue injured endothelial cells in an in vitro ischemia-reperfusion model via tunneling nanotube like structure-mediated mitochondrial transfer","volume":"92","author":"Liu","year":"2014","journal-title":"Microvasc. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1038\/ncomms9472","article-title":"Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs","volume":"6","author":"Phinney","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Torralba, D., Baixauli, F., and S\u00e1nchez-Madrid, F. (2016). Mitochondria Know No Boundaries: Mechanisms and Functions of Intercellular Mitochondrial Transfer. Front. Cell Dev. Biol., 4.","DOI":"10.3389\/fcell.2016.00107"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14653240310003611","article-title":"Immunomodulatory effects of fetal and adult mesenchymal stem cells","volume":"5","year":"2003","journal-title":"Cytotherapy"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/scrt216","article-title":"Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells","volume":"4","author":"Kurte","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/scrt55","article-title":"Mesenchymal stem cell-based therapies in regenerative medicine: Applications in rheumatology","volume":"2","author":"Maumus","year":"2011","journal-title":"Stem Cell Res. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/1756283X16642190","article-title":"Stem cell-based therapies in inflammatory bowel disease: Promises and pitfalls","volume":"9","author":"Duran","year":"2016","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1089\/scd.2013.0479","article-title":"Mesenchymal stem cells secrete immunologically active exosomes","volume":"23","author":"Zhang","year":"2014","journal-title":"Stem Cells Dev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7150\/thno.16154","article-title":"Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: Implications for nanomedicine","volume":"7","author":"Roura","year":"2017","journal-title":"Theranostics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"914","DOI":"10.4252\/wjsc.v13.i7.914","article-title":"Current advances of stem cell-based therapy for kidney diseases","volume":"13","author":"Wong","year":"2021","journal-title":"World J. Stem Cells"},{"key":"ref_30","first-page":"83","article-title":"Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method","volume":"2","author":"Friedenstein","year":"1974","journal-title":"Exp. Hematol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4939-2938-2_4","article-title":"Mesenchymal Stem Cells Derived from Human Adipose Tissue","volume":"1340","author":"Mahmoudifar","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_32","first-page":"1017","article-title":"Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials","volume":"91","author":"Lu","year":"2006","journal-title":"Haematologica"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.7150\/ijms.8356","article-title":"Oxidative stress-induced premature senescence in Wharton\u2019s jelly-derived mesenchymal stem cells","volume":"11","author":"Choo","year":"2014","journal-title":"Int. J. Med Sci."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Talwadekar, M.D., Kale, V.P., and Limaye, L.S. (2015). Placenta-derived mesenchymal stem cells possess better immunoregulatory properties compared to their cord-derived counterparts\u2014A paired sample study. Sci. Rep., 5.","DOI":"10.1038\/srep15784"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Longhini, A.L.F., Salazar, T.E., Vieira, C., Trinh, T., Duan, Y., Pay, L.M., Calzi, S.L., Losh, M., Johnston, N.A., and Xie, H. (2019). Peripheral blood-derived mesenchymal stem cells demonstrate immunomodulatory potential for therapeutic use in horses. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0212642"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5932706","DOI":"10.1155\/2017\/5932706","article-title":"Isolation and molecular characterization of amniotic fluid-derived mesenchymal stem cells obtained from caesarean sections","volume":"2017","author":"Spitzhorn","year":"2017","journal-title":"Stem Cells Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"101465","DOI":"10.1016\/j.scr.2019.101465","article-title":"Skeletal-muscle-derived mesenchymal stem\/stromal cells from patients with osteoarthritis show superior biological properties compared to bone-derived cells","volume":"38","author":"Presen","year":"2019","journal-title":"Stem Cell Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3892\/ijmm.2014.1821","article-title":"Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation","volume":"34","author":"Li","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/sctm.19-0044","article-title":"Challenges in Clinical Development of Mesenchymal Stromal\/Stem Cells: Concise Review","volume":"8","author":"Mastrolia","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Rota, C., Morigi, M., and Imberti, B. (2019). Stem Cell Therapies in Kidney Diseases: Progress and Challenges. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112790"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/nep.12018","article-title":"Systematic review and meta-analysis of mesenchymal stem\/stromal cells therapy for impaired renal function in small animal models","volume":"18","author":"Wang","year":"2013","journal-title":"Nephrology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"s45","DOI":"10.1590\/1806-9282.66.s1.45","article-title":"Mesenchymal stem cell therapy in acute kidney injury (AKI): Review and perspectives","volume":"66","author":"Rangel","year":"2020","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_43","first-page":"281","article-title":"Cell-based therapies for experimental chronic kidney disease: A systematic review and meta-analysis","volume":"8","author":"Papazova","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/s13287-019-1507-3","article-title":"Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: A review with a focus on preclinical models","volume":"10","author":"Zhao","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1089\/scd.2011.0722","article-title":"Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells","volume":"21","author":"Strioga","year":"2012","journal-title":"Stem Cells Dev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5966\/sctm.2012-0184","article-title":"Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts","volume":"2","author":"Melief","year":"2013","journal-title":"Stem Cells Transl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.109.898312","article-title":"Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice","volume":"121","author":"Lian","year":"2010","journal-title":"Circulation"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.juro.2008.07.023","article-title":"Urine derived cells are a potential source for urological tissue reconstruction","volume":"180","author":"Zhang","year":"2008","journal-title":"J. Urol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/stem.1424","article-title":"Multipotential differentiation of human urine-derived stem cells: Potential for therapeutic applications in urology","volume":"31","author":"Bharadwaj","year":"2013","journal-title":"Stem Cells"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gendis.2014.07.001","article-title":"Urine-derived stem cells: A novel and versatile progenitor source for cell-based therapy and regenerative medicine","volume":"1","author":"Zhang","year":"2014","journal-title":"Genes Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1089\/scd.2008.0320","article-title":"Isolation and characterization of resident mesenchymal stem cells in human glomeruli","volume":"18","author":"Bruno","year":"2009","journal-title":"Stem Cells Dev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13287-017-0478-5","article-title":"The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury","volume":"8","author":"Ranghino","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5966\/sctm.2016-0053","article-title":"Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine","volume":"6","author":"Leuning","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3892\/etm.2016.3109","article-title":"Protective effect of adipose-derived mesenchymal stem cells against acute kidney injury induced by ischemia-reperfusion in Sprague-Dawley rats","volume":"11","author":"Sheashaa","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1479-5876-9-51","article-title":"Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction","volume":"9","author":"Chen","year":"2011","journal-title":"J. Transl. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ki.2013.114","article-title":"Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions","volume":"84","author":"Hu","year":"2013","journal-title":"Kidney Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10529-010-0207-y","article-title":"Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia\/reperfusion-induced acute renal failure in rats","volume":"32","author":"Cao","year":"2010","journal-title":"Biotechnol. Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3727\/096368911X623925","article-title":"Adipose tissue-derived stem cell treatment prevents renal disease progression","volume":"21","author":"Semedo","year":"2012","journal-title":"Cell Transplant."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/ndt\/gfr015","article-title":"Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury","volume":"26","author":"Gatti","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1681\/ASN.2014070710","article-title":"AKI Recovery Induced by Mesenchymal Stromal Cell-Derived Extracellular Vesicles Carrying MicroRNAs","volume":"26","author":"Collino","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12015-016-9713-1","article-title":"Exosome and Microvesicle-Enriched Fractions Isolated from Mesenchymal Stem Cells by Gradient Separation Showed Different Molecular Signatures and Functions on Renal Tubular Epithelial Cells","volume":"13","author":"Collino","year":"2017","journal-title":"Stem Cell Rev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.transproceed.2010.03.079","article-title":"Mesenchymal stem cells infusion prevents acute cellular rejection in rat kidney transplantation","volume":"42","author":"Zonta","year":"2010","journal-title":"Transplant. Proc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1432-2277.2011.01328.x","article-title":"In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia","volume":"24","author":"Hara","year":"2011","journal-title":"Transpl. Int."},{"key":"ref_64","first-page":"a015560","article-title":"Mesenchymal Stem\/Stromal Cells in Organ Transplantation","volume":"3","author":"Dayanand","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Seifert, M., Stolk, M., Polenz, D., and Volk, H.D. (2012). Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejection. Front. Immunol., 3.","DOI":"10.3389\/fimmu.2012.00202"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/TP.0b013e31819b3d72","article-title":"Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients","volume":"87","author":"Crop","year":"2009","journal-title":"Transplantation"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Perico, N., Casiraghi, F., Todeschini, M., Cortinovis, M., Gotti, E., Portalupi, V., Mister, M., Gaspari, F., Villa, A., and Fiori, S. (2018). Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01359"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.2012.316","article-title":"Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: A randomized controlled trial","volume":"307","author":"Tan","year":"2012","journal-title":"JAMA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/scitranslmed.3003509","article-title":"Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation","volume":"4","author":"Leventhal","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e143606","DOI":"10.1172\/jci.insight.143606","article-title":"Intravenous allogeneic umbilical cord blood\u2013derived mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa patients","volume":"6","author":"Lee","year":"2021","journal-title":"JCI Insight"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1600-6143.2012.04115.x","article-title":"Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation","volume":"12","author":"Casiraghi","year":"2012","journal-title":"Am. J. Transplant."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s13287-023-03587-y","article-title":"The heterogeneity of mesenchymal stem cells: An important issue to be addressed in cell therapy","volume":"14","author":"Li","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Olmedo-Moreno, L., Aguilera, Y., Bali\u00f1a-S\u00e1nchez, C., Mart\u00edn-Montalvo, A., and Capilla-Gonz\u00e1lez, V. (2022). Heterogeneity of In Vitro Expanded Mesenchymal Stromal Cells and Strategies to Improve Their Therapeutic Actions. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14051112"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12967-024-05294-5","article-title":"Unveiling heterogeneity in MSCs: Exploring marker-based strategies for defining MSC subpopulations","volume":"22","author":"Chen","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Santos, M.E., Garcia-Arranz, M., Andreu, E.J., Garc\u00eda-Hern\u00e1ndez, A.M., L\u00f3pez-Parra, M., Villar\u00f3n, E., Sep\u00falveda, P., Fern\u00e1ndez-Avil\u00e9s, F., Garc\u00eda-Olmo, D., and Prosper, F. (2022). Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.918565"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Mali\u010dev, E., and Jazbec, K. (2024). An Overview of Mesenchymal Stem Cell Heterogeneity and Concentration. Pharmaceuticals, 17.","DOI":"10.3390\/ph17030350"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1875692111008010025","article-title":"Personalizing Stem Cell Research and Therapy: The Arduous Road Ahead or Missed Opportunity?","volume":"8","author":"Patel","year":"2010","journal-title":"Curr. Pharmacogenomics Person. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/nep.12258","article-title":"Mesenchymal stem cells and transplant tolerance","volume":"19","author":"Vanikar","year":"2014","journal-title":"Nephrology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/stem.1982","article-title":"Establishing Criteria for Human Mesenchymal Stem Cell Potency","volume":"33","author":"Samsonraj","year":"2015","journal-title":"Stem Cells"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.15419\/bmrat.v6i4.538","article-title":"The subpopulation of CD105 negative mesenchymal stem cells show strong immunomodulation capacity compared to CD105 positive mesenchymal stem cells","volume":"6","author":"Pham","year":"2019","journal-title":"Biomed. Res. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","article-title":"Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex","volume":"57","author":"Tammik","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5581\/1516-8484.20130017","article-title":"Immunological characteristics of mesenchymal stem cells","volume":"35","author":"Machado","year":"2013","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","article-title":"Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells","volume":"26","author":"Selmani","year":"2008","journal-title":"Stem Cells"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.4049\/jimmunol.181.6.3933","article-title":"Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells","volume":"181","author":"Casiraghi","year":"2008","journal-title":"J. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14653240601045399","article-title":"Mesenchymal stromal cells: Tissue repair and immune modulation","volume":"8","year":"2006","journal-title":"Cytotherapy"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2215\/CJN.04950610","article-title":"Autologous Mesenchymal Stromal Cells and Kidney transplantation: A Pilot study of safety and clinical feasibility","volume":"6","author":"Perico","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2017.07.024","article-title":"Six years\u2019 experience of tolerance induction in renal transplantation using stem cell therapy","volume":"187","author":"Aruna","year":"2018","journal-title":"Clin. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2141.2005.05409.x","article-title":"Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells","volume":"129","author":"Puissant","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.imlet.2009.07.010","article-title":"Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells","volume":"126","author":"Bochev","year":"2009","journal-title":"Immunol. Lett."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cellimm.2009.06.010","article-title":"Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues","volume":"259","author":"Yoo","year":"2009","journal-title":"Cell. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Takemitsu, H., Zhao, D., Yamamoto, I., Harada, Y., Michishita, M., and Arai, T. (2012). Comparison of bone marrow and adipose tissue-derived canine mesenchymal stem cells. BMC Vet. Res., 8.","DOI":"10.1186\/1746-6148-8-150"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Dedier, M., Magne, B., Nivet, M., Banzet, S., and Trouillas, M. (2023). Anti-inflammatory effect of interleukin-6 highly enriched in secretome of two clinically relevant sources of mesenchymal stromal cells. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1244120"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Jimenez-Puerta, G.J., Marchal, J.A., L\u00f3pez-Ruiz, E., and G\u00e1lvez-Mart\u00edn, P. (2020). Role of Mesenchymal Stromal Cells as Therapeutic Agents: Potential Mechanisms of Action and Implications in Their Clinical Use. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020445"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cellimm.2010.06.006","article-title":"Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton\u2019s jelly and bone marrow sources","volume":"264","author":"Najar","year":"2010","journal-title":"Cell Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ki.2015.88","article-title":"Kidney donation after circulatory death (DCD): State of the art","volume":"88","author":"Summers","year":"2015","journal-title":"Kidney Int."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"S\u00fcsal, C., Mueller, T.F., Legendre, C., and Schemmer, P. (2020). Editorial: Transplantation of Marginal Organs\u2014Immunological Aspects and Therapeutic Perspectives. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.612576"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/TP.0b013e3182a19348","article-title":"Defining delayed graft function after renal transplantation: Simplest is best","volume":"96","author":"Mallon","year":"2013","journal-title":"Transplantation"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Nieuwenhuijs-Moeke, G.J., Pischke, S.E., Berger, S.P., Sanders, J.S.F., Pol, R.A., Struys, M.M.R.F., Ploeg, R.J., and Leuvenink, H.G.D. (2020). Ischemia and Reperfusion Injury in Kidney Transplantation: Relevant Mechanisms in Injury and Repair. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010253"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ebiom.2018.01.025","article-title":"Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond","volume":"28","author":"Zhao","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_100","first-page":"233","article-title":"Mesenchymal stem cell therapy for chronic kidney disease","volume":"24","author":"Beyth","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: Clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00005-019-00541-w","article-title":"Post-transplant Alternative Complement Pathway Activation Influences Kidney Allograft Function","volume":"67","author":"Bartoszek","year":"2019","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1084\/jem.176.6.1497","article-title":"Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease","volume":"176","author":"Matsushita","year":"1992","journal-title":"J. Exp. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4252\/wjsc.v7.i8.1090","article-title":"Complement activation in the context of stem cells and tissue repair","volume":"7","author":"Ingrid","year":"2015","journal-title":"World J. Stem. Cells"},{"key":"ref_105","first-page":"894752","article-title":"Complement activation in mesenchymal stem cell therapy: A comparison of different infusion strategies","volume":"2015","author":"Bennett","year":"2015","journal-title":"J. Immunol. Res."},{"key":"ref_106","first-page":"128","article-title":"Complement activation and its impact on stem cell therapy: Evaluation in various MSC infusion protocols","volume":"12","author":"Levy","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_107","first-page":"75","article-title":"Comparative analysis of complement activation in various protocols of mesenchymal stem cell infusion","volume":"198","author":"Liu","year":"2018","journal-title":"Immunol. Lett."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/19\/5763\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:04:48Z","timestamp":1760112288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/19\/5763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":107,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["jcm13195763"],"URL":"https:\/\/doi.org\/10.3390\/jcm13195763","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]}}}